Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I–III breast cancer?
Crossref DOI link: https://doi.org/10.1007/s10552-017-0851-9
Published Online: 2017-02-16
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cahir, Caitriona
Barron, Thomas I.
Sharp, Linda
Bennett, Kathleen
Funding for this research was provided by:
Health Research Board (ICE-2011-9, HRA-2009-221)
Irish Cancer Society (CCRC13GAL)
License valid from 2017-02-16